Both the PI3K/AKT pathway and MAPK pathway were marked as significant pathways in our network pharmacology analysis, which suggested that BHHD could directly regulate INS-related pathways, such as FoxO signalling pathway, INS resistance, type II diabetes, and INS signalling pathway. The gene discussed is AKT1; the disease is type 2 diabetes mellitus.